VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
Original Article
Z. Cao, W. Gao, H. Bao, H. Feng, S. Mei, P. Chen, Y. Gao, Z. Cui, Q. Zhang, X. Meng, H. Gui, W. Wang, Y. Jiang, Z. Song, Y. Shi, J. Sun, Y. Zhang, Q. Xie, Y. Xu, G. Ning, Y. Gao, and R. Zhao
N Engl J Med 2023;388:406-417
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation